[Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
D000818:Animals; D001381:Azepines / Q000494:pharmacology; D001786:Blood Glucose / Q000378:metabolism*; D004285:Dogs; D004386:Duodenum / Q000098:blood supply; D005947:Glucose / Q000494:pharmacology; D007003:Hypoglycemia / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects; D010080:Oxazoles / Q000494:pharmacology; D010179:Pancreas / Q000098:blood supply / Q000187:drug effects; D011863:Radioimmunoassay; D013453:Sulfonylurea Compounds / Q000494:pharmacology*
D001381:Azepines; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D010080:Oxazoles; D013453:Sulfonylurea Compounds; D005947:Glucose
Rôle du taux de la glycémie sur la sécrétion d'insuline provoquée chez le chien par un sulfamide hypoglycémiant, le glisoxepide.